Casi Pharmaceuticals Inc (CASI)
1.85 x 1 3.00 x 10
Post-market by (Cboe BZX)
2.30 unch (unch) 03/20/25 [NASDAQ]
1.85 x 1 3.00 x 10
Post-market 1.91 -0.39 (-16.96%) 14:31 ET
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,400 | -35,842 | -30,447 | -20,428 | -13,684 |
| Depreciation Amortization | 433 | 1,815 | 1,402 | 981 | 516 |
| Accounts receivable | -283 | -5,158 | -773 | -1,122 | -1,193 |
| Accounts payable and accrued liabilities | 2,378 | 1,491 | 26 | 884 | 2,073 |
| Other Working Capital | -42 | -1,938 | -2,433 | -2,935 | -1,111 |
| Other Operating Activity | 1,676 | 12,790 | 13,024 | 7,279 | 5,398 |
| Operating Cash Flow | $-4,238 | $-26,842 | $-19,201 | $-15,341 | $-8,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,288 | -8,935 | -3,730 | -1,208 | -981 |
| Net Acquisitions | N/A | -86 | N/A | -5,500 | -86 |
| Purchase Sale Intangibles | N/A | N/A | 10 | N/A | N/A |
| Other Investing Activity | 0 | -11,670 | -12,220 | -6,336 | -11,000 |
| Investing Cash Flow | $-2,288 | $-20,691 | $-15,950 | $-13,044 | $-12,067 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 709 | 709 | 709 | 709 |
| Debt Repayment | N/A | -1,548 | -463 | N/A | N/A |
| Common Stock Issued | N/A | 32,500 | 32,500 | 32,500 | 32,500 |
| Common Stock Repurchased | -3,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -2,019 | -2,019 | -2,019 | -2,019 |
| Financing Cash Flow | $-3,000 | $29,642 | $30,727 | $31,190 | $31,190 |
| Exchange Rate Effect | 81 | -469 | 486 | 488 | -69 |
| Beginning Cash Position | 38,704 | 57,064 | 57,064 | 57,064 | 57,064 |
| End Cash Position | 29,259 | 38,704 | 53,126 | 60,357 | 68,117 |
| Net Cash Flow | $-9,445 | $-18,360 | $-3,938 | $3,293 | $11,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,238 | -26,842 | -19,201 | -15,341 | -8,001 |
| Capital Expenditure | -2,288 | -8,945 | -3,730 | -1,208 | -981 |
| Free Cash Flow | -6,526 | -35,787 | -22,931 | -16,549 | -8,982 |